ABILITA BIO
Abilita Bio was founded in June 2014 and is a biotechnology company focused on enabling discovery and development of drugs targeting membrane proteins, including G Protein Coupled Receptors (GPCRs) and ion channels. We have established collaborations, and seek to expand collaborative research agreements with global pharmaceutical and biotechnology companies. We are currently incubating in JLabs San Diego (a life science innovation center operated by Janssen Research & Development).
ABILITA BIO
Industry:
Biotechnology
Founded:
2014-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.abilitabio.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Wordpress Plugins Microsoft Exchange Online Office 365 Mail
Similar Organizations
AntiCancer Inc.
AntiCancer Inc. is a biotechnology company
Boston Pharmaceuticals
Boston Pharmaceuticals Provides Healthcare Services.
Genosco
Genosco is a biotechnology company.
KBP Biosciences
A multinational clinical stage biotechnology company.
MGP
MGP Inc is a technology company.
Snowflake
Snowflake Inc. is a data cloud company.
Current Employees Featured
Founder
Official Site Inspections
http://www.abilitabio.com Semrush global rank: 5.95 M Semrush visits lastest month: 1.39 K
- Host name: server72-1.web-hosting.com
- IP address: 198.54.114.219
- Location: Los Angeles United States
- Latitude: 34.0318
- Longitude: -118.4252
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90064
More informations about "Abilita Bio"
Abilita Bio - Crunchbase Company Profile & Funding
Contact Email [email protected] Abilita Bio is a biotechnology company that focuses on enabling the discovery and development of drugs targeting membrane proteins, including G …See details»
team – Abilita Therapeutics
Tom’s responsibilities grew from Scientist to Director and he developed proprietary processes used to produce recombinant G-CSF and other therapeutic candidates for clinical applications. …See details»
Abilita Therapeutics, Inc. | LinkedIn
Abilita Therapeutics, Inc. | 2,173 followers on LinkedIn. Redefining the druggable landscape for membrane protein targets | Abilita Therapeutics is a biotechnology company focused on redefining ...See details»
Abilita Therapeutics – LEADER IN DISCOVERING AND …
Feb 21, 2023 Granting access to medically important targets among the hundreds that are currently considered ‘intractable’ or ‘undruggable’ Providing the unparalleled opportunity to directly use purified proteins for discovery processesSee details»
Abilita | Seed - National Institutes of Health
Abilita Bio is a private biotechnology company focused on leveraging its proprietary EMP membrane protein stabilization technologies to become the leader in discovering and …See details»
TECHNOLOGY – Abilita Therapeutics
Abilita Therapeutics is an innovation-driven biotechnology company focused on enabling discovery and development of drugs targeting challenging membrane proteins, including G Protein-Coupled Receptors (GPCRs) and ion channelsSee details»
Abilita Bio Changes Name to Abilita Therapeutics and …
Jun 1, 2023 Name change to Abilita Therapeutics reflects the company's focus and newly established capabilities to build an internal pipeline of first- and best-in-class therapeuticsSee details»
Abilita Bio - Craft
Abilita Bio has 5 employees at their 1 location. See insights on Abilita Bio including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Abilita Bio Announces Business Growth and Key Developments
Jan 9, 2020 6888 Nancy Ridge Drive, San Diego, California 92121, USA. [+1] 858-246-6778; [email protected]; Facebook Twitter LinkedinSee details»
Abilita Bio Changes Name to Abilita Therapeutics and ... - BioSpace
Jun 1, 2023 Aligned with the company's expanded mission, Abilita Therapeutics announced the appointment of Joel Edwards as chief business officer, effective June 1, 2023.He will serve as …See details»
Two Bear Capital
After honing internal antibody discovery skills to complement the EMP™ system, Abilita is actively building a large pipeline of internal assets, and will foster comprehensive research …See details»
Abilita Bio Announces Business Growth and Key Developments
SAN DIEGO, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Abilita Bio, Inc., an innovation-driven biotechnology company focused on enabling discovery and development of drugs targeting …See details»
Abveris and Abilita Bio Announce a Discovery Collaboration to …
Aug 24, 2021 SAN DIEGO and CANTON, Mass., Aug. 24, 2021 /PRNewswire/ -- Abveris, Inc. ("Abveris") and Abilita Bio, Inc. ("Abilita"), both privately held biotechnology companies, …See details»
Abilita Bio Changes Name to Abilita Therapeutics and Appoints …
Jun 1, 2023 Name change to Abilita Therapeutics reflects the company's focus and newly established capabilities to build an internal pipeline of first- and be...See details»
Abveris and Abilita Bio Announce Collaboration to Develop …
Canton, MA, USA--(San Diego, CA, USA)--Abveris, Inc. (“Abveris”) and Abilita Bio, Inc. (“Abilita”), both privately held biotechnology companies, announce a joint research collaboration that will …See details»
ABILITA BIO SECURES $7.5 MILLION IN EQUITY FINANCING FROM …
Feb 21, 2023 For more information, visit www.abilitabio.com. Contact. Mauro Mileni [email protected] 858-246-6778. SOURCE Abilita Bio. WANT YOUR COMPANY'S NEWS …See details»
News – Abilita Therapeutics
Mar 23, 2022 February 13, 2019 Abilita Bio and Amgen Enter Into a Multi-Target Collaboration Abilita Bio, Inc., announced today that it has entered into a multi-target research collaboration …See details»
Abveris and Abilita Bio Announce a Discovery Collaboration to …
Aug 24, 2021 Abveris and Abilita Bio Announce a Discovery Collaboration to Develop Therapeutics for Challenging Membrane Protein Targets – The research collaboration will …See details»
Abilita Bio selected as one of San Diego’s ‘Cool Companies’ 2022
Abilita Bio will also participate as a ‘Cool Company’ to the first ‘San Diego Innovation Day’ event, organized by CONNECT on April 28 at Petko Park, San Diego.See details»
pipeline – Abilita Therapeutics
We are building a pipeline of high-value assets for partnering or advancing to clinical development.See details»